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Macrophages secrete a wide variety of biologically active products. Some of these, such 
as lysozyme (1) and certain degradative lysosomal enzymes (2) are well defined and have 
been purified and characterized physicochemically. Others, including additional lysoso- 
mal enzymes (2), collagenase (3), plasminogen activator (4), and elastase (5) have been 
largely defined  in  terms  of their  substrate  specificity.  A  third  group of macrophage 
secretory products has been defined on the basis of biological activity and includes colony 
stimulating  factor  (6), endogenous  pyrogen  (7),  a  cytelytic factor  (8),  a  lymphocyte 
mitogen (9), and an inhibitor of cell division (10). Cultures of macrophages have permit- 
ted  in vitro  studies  of the  control of rates  of synthesis  (11) and release  (12) of these 
secretory products and have contributed to an understanding of membrane structure (13) 
and function (14). In vitro studies have indicated that macrophages may help to initiate 
the antigenic stimulation of lymphocytes (15) and that they modulate lymphocyte secre- 
tion of such products as interferon (16) and osteoclast-activating factor (17). Macrophage 
cultures have also been useful in studies of lymphokine function (18) and host defenses 
against bacteria (19), mycoplasma (20), viruses (16), and tumors (21). 
A stem cell in bone marrow presumably gives rise to blood monocytes which circulate 
for 24-48 h and then become fixed in tissues as elements of the reticuloendothelial system 
(~12).  Blood  monocytes may  therefore  represent  a  convenient  source  of cells  for  the 
assessment  of macrophage  function.  In  previous  studies  of monocytes,  either  large 
volumes of blood were required (16, 23, 24) or the cells  could be maintained in vitro no 
longer than  17  days (1,  25). The present  study was made possible by development of 
techniques for preparation of confluent monolayers of pure monocytes which could be 
maintained in culture for up to 16 wk. 
Initial studies of the biosynthesis of the second component of complement (C2) indi- 
cated that hemolytically active C2 was detectable in media harvested from short-term 
cultures of guinea pig spleen, lung, lymph node, bone marrow, peritoneal exudate (PE), 1 
and  in  some cases  liver  (26, 27). C2 production was temperature-dependent  and  was 
reversibly inhibited by puromycin or cycloheximide; guinea pig spleen was capable of 
incorporating radiolabeled amino acids into immunochemically and functionally identifia- 
ble C2 (27). In subsequent studies  with the use of a  modification of the Jerne plaque 
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technique,  designed  to  detect  guinea  pig  C2  (28), and  by  albumin  density-gradient 
separation of human fetal cells (29) it was shown that C2 was produced by mononuclear 
cells from  PE  and  liver,  respectively.  C2  production  appeared  to  be  restricted  to  the 
adherent cell population in guinea pig PE (30). 
In  the  present  study,  pure  cultures  of human  monocytes  synthesized  and 
secreted  C2  for  up  to  16  wk  in  vitro.  In  addition,  these  cells were  capable  of 
synthesizing lysozyme, phagocytosing large latex beads, killingListeria monocy- 
togenes,  and forming rosettes with IgG or C3-coated erythrocytes. 
Materials and Methods 
Preparation ofMonocyte Monolayers.  Circular glass cover slips (15-mm diameter, no. 2, SGA 
Scientific, Inc., Bloomfield, N. J.) were thoroughly washed by dropping each of approximately 80 
slips into a solution of about 9 g of soap (Ivory Snow, Procter and Gamble, Cincinnati, Ohio) in 600 
ml of deionized water. To facilitate uniform washing, allundum boiling chips (Fisher Scientific 
Co., Pittsburgh, Pa.) were placed in the water bath and the mixture was boiled for 4 h. The slips 
were then rinsed 20 times with deionized water and boiled for an additional 4 h in deionized water. 
After 10 additional rinses in water they were exposed  to 1% Siliclad (Clay Adams, Parsippany, 
N. J.) in deionized water for 15 rain and rinsed again in deionized water five times. Slips were 
individually dried by placing them on Whatman filter paper and then autoclaved. This washing 
procedure  was  essential  for  preparation  of monocyte cultures  with  a  high  degree  of plating 
efficiency. 
Venous blood was drawn into a syringe containing 0.2 ml 6% dextran 75 (Travenol Laboratories, 
Morton Grove, Ill.) in sterile saline with 0.06 ml 0.1 M Na EDTA per ml of bloed. The blood was 
allowed to sediment in the syringe for 3 h after which the leukocyte-rich plasma was removed. The 
leukocytes were washed twice and then resuspended in Medium 199 (Microbiological  Associates, 
Bethesda, Md.). Between washes the cells were collected by low speed centrifugation (190gmax, 15 
rain 4°C). The washed cell suspensions were incubated at 4°C for 16 h to permit loss of a substantial 
portion of polymorphonuclear leukocytes capable of adhering to glass. The leukocytes were then 
vigorously resuspended by pipetting, to avoid cell clumping, washed again in M199, and a portion 
resuspended at a concentration of approximately 3  x  106 mononuclear cells/ml in M199 supple- 
mented with 10% heat-inactivated (56°C, 2 h) autelogous serum (M199 HAS). 0.2-ml portions were 
immediately placed on individual cover slips resting on sterile rubber stoppers (plugs from 3-ml. 
Vacutainer tubes, Becton-Dickinson & Co., Rutherford, N. J.) in plastic petri dishes (Falcon Plas- 
tics, Oxnard, Calif.). After 2 h incubation at 37°C in humidified 5% CO~:95% air atmosphere the 
slips were rinsed twice by vigorous agitation in each of two beakers containing M199. To obtain con- 
fluent monolayers this procedure was repeated using portions of the suspension that were stored at 
4°C (in the absence of serum). A third application of 0.2 ml of the cell suspension was performed 
with the slips in individual wells of a Multi-Dish Disposo-Tray (FB-16-24-TC, Linbro Chemical Co., 
New Haven, Conn.) to permit settling of monocytes at the periphery of  the cover slips.  After 30 min 
at 37°C 0.3 ml of M199 HAS was added to each well and the cells reincubated for 90 min. Mono- 
layers were rinsed again in M199 then incubated for I day to 2 wk at 37°C in wells containing fresh 
M199 HAS (0.5 ml). After rinsing in M199, monolayers were transferred to wells containing 0.5 ml 
of M199 supplemented with  10%  heat-inactivated (56°C, 2 h)  fetal calf serum (M199 HFCS) at 
regular intervals for use in each experiment. Cell viability was assessed with trypan blue (Micro- 
biological  Associates). 
Fluorometric  Assay  ofDNA.  The number of  monocytes  on  a cover  slip  was determined  using  a 
modification  of  a previously  described  fluorometric  assay for  DNA  (31).  Cover  slips  were rinsed  in 
isotonic  saline,  then  resubmerged  in  0.5  ml  of  2% sodium  dodecyl sulfate  (Matheson,  Coleman and 
Bell,  Norwood, Ohio) in  deionized  water. The slips  were  incubated at  37°C  for  i  h, after  which the 
cell  lysate  solutions  were mixed  by  repeated pipetting.  Aliquots (0.46  ml)  of  the  lysate  were stored 
at -20°C in  conical  Eppendorf  Micro  Test  Tubes (Brinkman Instruments, Westbury, N. Y.).  20  ~l 
ofa i  mg/ml solution  ofpolyriboguanadylic acid  (Collaborative  Research, Inc.,  Waltham, Mass.)in 
100  mM  Tris,  10  mM  EDTA, pH 7.4,  was added to  each tube.  The tubes were gently  vortexed and 
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vortexed, and stored for at least 18 h  at  -20°C. Each sample was washed four times in absolute 
ethanol at 0°C with high speed centrifugation (12,000 gmax, 30 min) between washes. The superna- 
tant was removed and the pellet dried at 100°C. 25 ~1 of deionized water was added to each sample 
and  the  tubes  vortexed.  After 30  min  at  room temperature,  25  ~1  of 3,5-diaminobenzoic  acid 
dihydrochloride  2 (DABA) (0.26 g/ml DABA in deionized water, Gold Label, Aldrich Chemical Co., 
Milwaukee, Wisc.) was added to each tube. The tubes were capped, vortexed, then incubated at 
60°C  for  30  min.  1/2  ml  of 1.0  N  HC1  was  added  to  each  tube  and  the  relative fluorescence 
determined in a  Perkin-Elmer (MPF-3) fluorescence spectrophotometer (excitation 380-420 nm, 
emission  500  nm).  A  standard  curve  was  constructed  using  the  same  procedure  with  known 
amounts of calf thymus DNA (Sigma Chemical Co., St. Louis, Mo.). 
Rosettes.  Procedures  for rosette  formation  with  IgG-coated human  erythrocytes  (33),  with 
sheep erythrocytes (34), and with C3-coated sheep erythrocytes (35) were performed as previously 
described. 
Immunofluorescence.  Monolayers were rinsed in phosphate-buffered saline (PBS), incubated 1 
h at 4°C with fluorescein-conjugated rabbit antihuman immunoglobulin antibody, rinsed in PBS, 
and examined by fluorescence microscopy. For detection ofintracellular lysozyme, cells were fixed 
for  1 min in  ice-cold methanol,  dried,  and  incubated  (45  min,  room temperature)  with  rabbit 
antihuman  lysozyme antiserum,  rinsed in PBS, reincubated (45 min, room temperature) with a 
mixture  of fluorescein-conjugated  goat  antirabbit  antibody  and  rhodamine-conjugated  bovine 
serum (Difco Laboratories, Detroit, Mich.), rinsed in PBS, and viewed by fluorescence microscopy. 
Controls consisted of slips treated in an identical manner except that normal rabbit serum was 
substituted for the rabbit antilysozyme antiserum. 
Phagocytosis.  5.7 ~m diameter styrene divinylbenzene beads (Dow Diagnostics, Indianapolis, 
Ind.) were autoclaved, diluted in M199, and stored at 4°C. A suspension containing approximately 
20 beads per monocyte was added to the monolayers, and after incubation at 37°C, the slips were 
rinsed at timed intervals and examined by phase-contrast microscopy for particle uptake. 
Measurement of C2 Activity.  The source and preparation of reagents for hemolytic titration of 
C2 were given in reference (36) and the assay performed as described in reference 37.  To detect 
synthesis and secretion of C2 by monocyte cultures 0.05-ml aliquots of media were harvested at 
timed intervals and stored at -90°C. Samples were thawed and then diluted in isotonic Veronal- 
buffered saline sucrose (~ =  0.065,  pH 7.35)  for the hemolytic assay.  Other complement compo- 
nents were assayed as described in reference 36. 
Inhibition of Protein Synthesis.  Cycloheximide was purchased from Nutritional Biochemical 
Corp.  (Cleveland, Ohio), dissolved in M199  immediately before use,  filtered through  a  0.22  ~m 
Millipore filter (Millipore Corp., Bedford, Mass.), and diluted in M199 HFCS. 
Incorporation  of Radiolabeled Amino Acids  into  C2 Protein.  Incorporation  of radiolabeled 
amino acids into C2 protein was estimated by a procedure outlined elsewhere (29) using 14C-labeled 
lysine, leucine, isoleucine, and valine (New England Nuclear, Boston, Mass.) at a final concentra- 
tion of 10 ~Ci/ml. 
Measurement of Lysozyme Activity.  Lysozyme activity was  measured  with  the  Lyso-Plate 
assay as previously described (38). Micrococcus lysodeikticus  was purchased from Sigma Chemical 
Company. Absolute lysozyme concentration was estimated by comparison with a standard  solu- 
tion of human  lysozyme obtained by Dr.  David S.  Rosenthal from the urine of a  patient with 
monocytic leukemia. 
Bacteriolysis  ofL. Monocytogenes.  A previously described technique for the detection of killing 
of 3H-labeled Listeria monocytogenes  (19) was used. 
Electron  Microscopy  and Peroxidase  Cytochemistry.  Cell monolayers were rinsed in normal 
saline and fixed in 2% purified glutaraldehyde (Polysciences, Inc., Warrington, Pa.) in cacodylate 
buffer (0.1 M, pH 7.4) containing 0.1 M sucrose for 15 min at room temperature.  For endogenous 
peroxidase, the monolayers were next incubated with 1.4 mM 3,3'-diaminobenzidine tetrahydro- 
chloride (Sigma Chemical Co.) in Tris-HC1 buffer (0.05 M, pH 7.1) and 0.01% H~O2 for 45 min at 
room  temperature  and  then  rinsed  three  times  in  distilled  water  (39). All monolayers  were 
postfixed in 1.3% OsO4 in S-collidine (pH 7.4) for 1 h at 4°C (40), stained in situ with 1.5% uranyl 
acetate in maleate buffer (0.05 M, pH 6.2),  dehydrated in graded ethanol, and embedded in Epon 
(Shell Chemical Co., New York). After polymerization, the disk of polymerized Epon containing 
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the cell monolayer was separated from the culture support surface and cut into 4 mm  2 squares and 
glued to blank Epon blocks. Thin sections were cut parallel to the plane of the cell monolayer using 
a  diamond knife (E.I.  duPont de Nemours  &  Co.,  Wilmington,  Del.) on an LKB Ultrotome III 
(LKB Instruments, Inc., Rockville, Md.) and picked up on carbon-coated grids. Cells examined for 
endogenous peroxidase were left unstained, while those viewed by routine electron microscopy 
were counter-stained with lead citrate  (41).  Sections were examined in a  Phillips 300 electron 
microscope. 
Results 
Morphology 
After 2  days  in  culture,  monolayers consisted of round,  slightly flattened 
mononuclear cells,  less  than  10  ~m  in  diameter.  All  of the  cells contained 
peroxidase positive granules (Fig.  1 a) and fluoresced when treated with rabbit 
antihuman lysozyme antibody followed by fluorescein-conjugated goat antirab- 
bit immunoglobulin. After 2 wk in culture, the cells had spread to cover the 
entire cover slip (Fig.  1 b) and measured up to 80 ~m in diameter. None of the 
cells contained peroxidase positive granules at this time. There was heterogene- 
ity in cell shape, and multinucleated giant cells were frequently observed. After 
4 wk in culture, the cytoplasm of each monocyte was densely packed with lipid 
droplets, approximately 0.1-0.8 ~m in diameter (Fig.  1 c). Mitotic forms were 
never observed in these monolayers throughout 16 wk in vitro. On the average, 
slips contained a  mean of 1.1,  0.5,  and 0.3  ~g of DNA after 2, 4,  and 8 wk in 
culture, respectively. 1.0 ~g of DNA corresponds to approximately 1.0-1.5  × 105 
monocytes. Based on the DNA content it was  calculated that,  at  maximum 
density, each slip contained approximately 1-3 × 105 monocytes. Since between 
15 and 25 confluent cover slips could be obtained from 30 ml of normal human 
blood, the efficiency of monocyte collection was approximately 50%. 
Cell Surface Properties 
ROSETTE FORMATION.  After 8 wk in culture, separate monolayers (approxi- 
mately 104 cells/slip) were incubated for 30 min at room temperature in PBS (pH 
7.4)  containing approximately 107  sheep erythrocytes, erythrocytes sensitized 
with IgM antiForssman antibody and the third component of human comple- 
ment (EC3), or with human 0  + erythrocytes sensitized with IgG anti-D antibody. 
The monolayers were then rinsed and each slip scanned for rosette formation. 
All the cells in the monolayer preparations rosetted with EC3 and with IgG- 
coated erythrocytes, but none formed rosettes with sheep erythrocytes. 
SURFACE  STAININa.  Monolayers  (2  wk  in  culture,  approximately  105 
cells/slip) were incubated with fluorescein-conjugated rabbit antihuman immu- 
noglobulin and examined by fluorescence microscopy. None of the cells stained 
for surface immunoglobulins. 
Phagocytosis 
Monolayers in culture 2 days-10 wk were rinsed in M199 then incubated with 
approximately 20 5.7 ~m diameter latex beads per cell in M199 HFCS for 24 hr at 
37°C,  the cover slips  rinsed,  and each cell examined for uptake of the latex 
particles under phase-contrast microscopy. Under these conditions nearly 100% 
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FIG.  1.  (a)  Human  monocyte in culture for 2 days,  fixed and incubated for endogenous 
peroxidase.  Numerous  small,  round  vesicles  containing electron-dense  reaction product 
(arrows) are present in the cytoplasm,  x  12,200. (b) Human monocytes in culture for 2 wk. 
Phase-contrast x  157. (c) Human monocyte in culture for 4 wk, fixed and stained for routine 
electron microscopy. The cell is greatly enlarged as compared to the one shown in Fig.  1 a. 
The nucleus (N)  contains loose chromatin and a  prominent nucleolus.  The cytoplasm is 
replete with numerous lipid droplets (asterisks).  x  6,600. 
Synthesis and Secretion of C2 
KINETICS.  Separate  monolayer  preparations  (cell  density  1-30  ×  104/slip) 
from 10 normal  individuals were rinsed and  when incubated in 0.5 ml of fresh 
M199 HFCS after 1 day, 2 wk, 6 wk, and 14 wk in culture. At timed intervals, 
portions  of the  media  were removed and  assayed for functional  C2  with  the 
hemolytic assay.  After each 0.05-ml  sample was removed, an equal volume of 
fresh M199 HFCS was added to the wells. The resulting dilution was taken into 
account in calculating total C2 production. After a 6 day lag, C2 production was 
linear  in monolayers examined after  1 day in culture (Fig.  2 a).  No lag in C2 
production was detected in monolayers studied at 2-4 wk (Fig.  2 b) or 6-8 wk 
(Fig.  2 c) in vitro. Moreover, the average rates of synthesis and secretion of C2 
per  cell  were  twice  and  three  times  the  initial  rate  in  the  2-4  and  6-8  wk 120 
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FIG. 2.  Kinetics  of C2 production by peripheral blood monocytes from 10 normal individ- 
uals during 2-wk intervals in culture (a) 0-2 wk in vitro; (b) 2-4 wk in vitro;  (c) 6-8 wk in 
vitro.  Points,  mean C2 production;  vertical  bars, two standard deviations;  shaded areas, 
range; Eft. Mol.,  hemolytically effective molecules. 
cultures, respectively.  In the latter preparations, C2 was secreted at an average 
rate of approximately 30 mol/cell per rain. To test whether the progressive loss of 
cells with time and resulting change in cell density affected rates of C2 synthe- 
sis, monolayers were established at densities varying up to 12-fold (6-72  ×  103 
cells/slip).  The  rate  of  C2  production  was  unaffected  by  cell  density  when 
examined  during  the  6th  and  7th  wk  in  culture.  Significant  production  of 
hemolytic  C2 was detected  during the  15 and  16 wk  in culture,  however,  the 
fluorometric assay was insufficiently sensitive to measure the small amount of 
DNA  on  each  slip  after  16  wk  in  vitro,  precluding  calculation  of a  per  cell 
synthetic rate during that period. Lysates of normal monocyte monolayers (7 wk 
in culture)  contained  no detectable  intracellular  hemolytically  active  C2.  No 
functionally active C1, C4, C3, C8, or C9 were detected in media from monocyte 
monolayers. 
EFFECT OF CYCLOHEXIMIDE.  Replicate monolayers from a single individual (3 
wk in culture) were incubated in M199 HFCS or M199 HFCS containing cyclo- 
heximide (0.5/~g/ml)  for 48 h  at 37°C, after which each monolayer was rinsed. 
One of the preparations incubated in the presence of cycloheximide was fed with 
fresh  M199  HFCS  lacking  the  inhibitor  and  the  other  incubated  again  in 
medium  with  cycloheximide.  C2  secretion  was  monitored with  the  hemolytic 
assay.  As shown in Fig.  3, cycloheximide  inhibited  C2 production by approxi- 
mately 80%; C2 production was restored by removing the inhibitor. 
INCORPORATION OF  14C-LABELED AMINO ACIDS.  Extensively dialyzed  and  con- 
centrated  medium harvested from monolayers  (6 wk  in vitro)  incubated for 5 
days in the presence of 14C-labeled amino acids was mixed with normal human 
serum (to provide carrier protein) and placed in a well opposite rabbit antihu- 
man C2, C3, and C4 antisera.  Radioautography of the washed and dried Ouch- 
terlony plates revealed labeling of the C2, C3, and C4 precipitin bands (Fig. 4). L.  P.  EINSTEIN,  E.  E.  SCHNEEBERGER,  AND  H.  R.  COLTEN  121 
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FIG. 3.  Reversible effect of cycloheximide on C2 production by human monocytes: Three 
monolayers (3 wk in culture), one incubated in medium alone (A) and two in medium plus 
0.5  ~g/ml cycloheximide  (0).  After 48 hr all  slips washed and one of the two inhibited 
monolayers placed in medium lacking cycloheximide (©). 
Using the same procedure no labeled C2 was detected in medium harvested from 
monolayers incubated in the presence of cycloheximide (2 ~g/ml) or in medium 
to which '4C-labeled amino acids were added after harvesting from the culture 
slips. 
Production  of Lysozyme 
Secretion of lysozyme by monocyte monolayers was detected after 2 days in 
culture.  The  maximum  rate  of lysozyme secretion was  approximately  50,000 
enzymatically active molecules per cell per min,  and there was no significant 
change in rate of secretion by cells maintained from 2 to 10 wk in vitro (Table I). 
Bacteriolysis  of L. monocytogenes 
Monolayers  (5  wk  in  culture)  were  incubated  at  37°C  in  M199  containing 
approximately  107  [3H]thymidine-labeled L.  monocytogenes  per  slip.  After  10 
min the slips were rinsed vigorously in M199 and reincubated in M199 at 37°C. 
At timed intervals the monolayers were rinsed,  lysed,  and assayed for viable 
bacteria.  The  results  (Table II)  showed a  significant  decrease in viable orga- 
nisms up to 5 h, after which an increase in bacterial count was detected. 
Discussion 
Several  lines  of evidence indicate  that  the  method described in this  report 
yields pure human monocyte cultures.  None of the cells in these preparations 
rosetted  with  sheep  erythrocytes,  making  T  lymphocyte  contamination  un- 
likely.  None  of the  cells  in  the  monolayers  bound  fluoresceinated  anti-IgG 
antiserum,  but all  formed rosettes  with  IgG-  or  C3-coated erythrocytes.  The 
absence  of  surface  IgG  on  the  monocyte  monolayers  makes  B  lymphocyte 
contamination unlikely. All of the cells, at 2 days, contained peroxidase-positive 
granules  and  lysozyme,  and  throughout  the  time  in  vitro  were  capable  of 122  C2  SYNTHESIS  BY  HUMAN  MONOCYTES 
FIG.  4.  Radioimmunodiffusion analysis of incorporation of 14C-labeled amino acids  into 
complement proteins by human monocytes (6 wk in culture). Center well: dialyzed, concen- 
trated monocyte culture medium plus normal human serum. Outer wells: rabbit antisera to 
human complement components. 
ingesting latex particles. These features are characteristic of monocytes and not 
of lymphocytes (1, 25, 42). Finally, none of the cells had morphologic features of 
polymorphonuclear leukocytes, eosinophils, or basophils.  Several technical de- 
tails were essential to the preparation (with a high degree of plating efficiency) 
of pure monocyte monolayers which survived in culture for as long as 16 wk; (a) 
incubation of washed leukocytes at 4°C in medium without serum for 12-18 h 
before plating  to  decrease  the  number  of glass  adherent  polymorphonuclear 
leukocytes in the cell suspension, (b) resuspension of cell pellets before centrifu- 
gation  to  prevent  clumping,  (c)  careful  preparation  of cover  slips  to  permit 
efficient and  uniform  plating  of the  monocytes,  and  (d)  vigorous washing  of 
cover slips after adherence of the monocytes to remove cell debris and contami- 
nating,  but less firmly adherent,  cell types. 
Evidence that these pure monocyte monolayers synthesized the second compo- 
nent of complement was based on observations that  (a)  biologically active C2 
was secreted into the medium in cultures maintained for several months; (b) C2 
secretion was reversibly inhibited by low concentrations (0.5 ~g/ml) of cyclohexi- 
mide,  a  well  known  inhibitor  of protein  synthesis;  (c)  production  of C2  was 
accompanied by incorporation  of 14C-labeled amino acids into C2 protein.  The 
rates of C2 synthesis varied as a function of  time in vitro. The rate of synthesis of 
C2 by monocytes maintained for 8 wk in culture was approximately three times 
the rate during the 2nd wk in culture. Moreover, a significant lag in onset of C2 
secretion was noted in the early cultures but was not detected in preparations 
maintained for 2 wk or more before measuring C2 synthesis. This lag may be a 
result of maturation of the monocytes early in culture.  Morphologic evidence of 
maturation in vitro included loss of peroxidase positive granules and formation 
of extensive cytoplasmic processes. 
Local synthesis of C2 by monocytes at a site of an inflammatory exudate may 
be of importance  in supporting  complement dependent  host defenses.  C2  is a 
limiting  component  in  the  activation  of the  classical  complement  pathway, 
inasmuch as the concentration of C2 in serum (43) is relatively low (on a  molar 
basis 10-fold less than C4 [44] and 40-fold less than C3 [45]) and the C~ complex 
is  unstable  (46).  C4-2, the  enzyme  that  cleaves  C3  in  the  classical  pathway, 
decays, liberating an inactive C2 molecule and a  C4 site capable of reaccepting 
active  C2  to regenerate  the  enzyme.  Local production  of C2  may circumvent L.  P.  EINSTEIN,  E.  E.  SCHNEEBERGER,  AND  H.  R.  COLTEN  123 
TABLE  I 
Lysozyme Production by Human Monocytes In Vitro 
Time In vitro*  LysozymeS 
wk  gg/monolayer 
0-2  1.5 
2-4  2.5 
4-6  2.5 
6-8  2.0 
8-10  2.4 
* Culture  media pooled at  2-wk  intervals from multiple monolayers 
obtained from each of eight normal individuals. 
S Mean  lysozyme  production  per  monolayer  (104  -  3  ×  105  mono- 
cytes/monolayer) during a  2-wk interval. 
TABLE  II 
Bacteriolysis by Human Monocytes In Vitro 
Hours In vitro* 
Viable L. monocytogenes/l~g monocyte proteins 
Exp. 1  Exp. 2 
0  1,100  1,000 
5  29  12 
24  5.6 ×  105  4.4  ×  10  s 
* 107 L. monocytogenes added to each of six monolayers (5-wk-old mono- 
layers,  approximately  105  monocytes/monolayer). After  10  min  all 
monolayers  were  rinsed  and  two  assayed  for  viable  bacteria  and 
protein (0  hr).  Remaining monolayers were rinsed and  assayed in 
duplicate after 5 h  and 24 h, respectively. 
$ Mean of duplicate determinations. 
these limiting effects by increasing the C2 concentration at a  site of inflamma- 
tion. 
Earlier studies suggested that the human peritoneal macrophage was a site of 
synthesis of the fourth (C4) and third (C3) components of complement (47). This 
conclusion  was  based solely on  detection of radiolabeled  precipitin  arcs  with 
immunoelectrophoresis  of culture media mixed with normal  serum as carrier 
protein.  In the present study, radiolabeled C3 and C4 bands were detected by 
immunoprecipitation  of media harvested from monocytes incubated  with  14C- 
labeled amino acids.  Nonetheless,  production of functional C3 and C4 was not 
detected, although  the functional  assays are capable of measuring  less than  1 
ng/ml of the respective proteins.  In addition,  synthesis of biologically active C3 
and  C4  was  easily demonstrated  in  short-term  cultures  of human  liver  (29). 
Several possible explanations for the discrepency between the immunochemical 
and functional data have been considered. Among these is the possibility that, 
since serum was used as a  source of carrier protein,  some other labeled macro- 
phage product coprecipitated with carrier (unlabeled) C3 and C4. On the other 
hand, postsynthetic degradation or inhibition of C3 and C4 activities may have 124  C2  SYNTHESIS  BY  HUMAN  MONOCYTES 
occurred.  Thus  it  is  not possible  at  the  present  time  to  determine whether 
human monocytes are in fact capable of synthesizing C3 and C4. 
Recently Gordon et al.  (1) reported that mouse peritoneal macrophages and 
human  monocytes  synthesize  lysozyme,  and  that  this  protein  accounts  for 
approximately 2% of the secreted mouse macrophage products.  We have con- 
firmed their observations in human monocytes and find that lysozyme secretion 
persists up to at least 12 wk in vitro. In the present study, the rate of lysozyme 
secretion was  approximately 1,500  times greater,  on a  molar basis,  than the 
maximal rate of C2 synthesis.  All of the cells in the culture were apparently 
producing lysozyme, as judged by immunofluorescent antibody studies, but no 
estimate has been obtained of the proportion of cells per culture that synthesize 
C2.  Therefore,  a  precise  ratio  of the  relative  rates  of synthesis  of C2  and 
lysozyme must await further studies. 
Summary 
A  method  has  been  developed for preparation of confluent monolayers of 
human monocytes from small volumes of blood and for maintenance of these 
pure monocyte cultures for up to 16 wk in vitro. These cells phagocytosed 5.7 ~zm 
diameter latex beads,  rosetted with erythrocytes coated with IgG or with C3, 
killed Listeria  monocytogenes,  and synthesized both lysozyme and the second 
component of complement. Lysozyme was secreted at a  rate of approximately 
50,000  mol/min per cell for at least 12 wk in cultures. The maximal rate of C2 
synthesis and secretion was considerably less; i.e.,  approximately 30 mol/min 
per cell between the 2nd and 12th wk in culture. Monocytes produced little C2 
during the first 6 days in culture after which a marked increase in the rate of C2 
production was noted. This increase was coincident with morphologic evidence 
of monocyte maturation. 
We are indebted to Ms. Beatrice Leigh, Mr. Manabu Nobuoka, and Ms. Ileana M. Fajardo for their 
technical assistance. We thank  Doctors Chester A. Alper, Joel S.  Greenberger, and John  G. 
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immunoglobulin, respectively. 
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